Currently, the most relevant data are those for cyclosporine, alitretinoin, and dupilumab.
Cyclosporine and dupilumab showed to be effective in the treatment of atopic dermatitis …

Background: The clinical features of adult-onset atopic dermatitis (AD) are heterogeneous
and the diagnosis can be a challenge. A new biologic drug (dupilumab) has been approved …

Background Systemic medications are often required for severe atopic dermatitis (AD)
refractory to topical therapies. Biologic medications are a recent advancement in the field …

With an increasing prevalence during the past decades, atopic dermatitis has become a
global health issue. A literature search following a targeted approach was undertaken to …

Atopic dermatitis (AD) is a pruritic, chronic and inflammatory skin disease, with an usual
onset in the pediatric age. Several drugs are used in the treatment of this skin disease …

Atopic dermatitis (AD) is a frequent, chronic remittent skin disease. The pathophysiology of
AD has been increasingly understood within the last years, which may help to identify …

Atopic dermatitis (AD) of the adult is a common skin disease. Its prevalence has greatly
increased during the past decades. AD is commonly associated with other atopic disorders …

Background Atopic dermatitis is a common, chronically recurring inflammatory skin disease.
It gives rise to a high disease burden and is of major importance in social medicine. Methods …

Atopic dermatitis (AD) in older adults (elderly AD) has recently emerged as a newly defined
subgroup of AD. When selecting treatment options, clinical characteristics of elderly AD and …

Background Treatment of moderate‐to‐severe atopic dermatitis (AD) in the elderly may be
challenging, due to side‐effects of traditional anti‐inflammatory drugs and to comorbidities …